Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Claudio, Knuesli"'
Autor:
Christine Biaggi, Claudio Knuesli, Daniela Bärtschi, John O. Prior, Sebastian Bauer, Angela Cioffi, Axel Le Cesne, Dieter Koeberle, Michael Montemurro, Philippe A. Cassier, Arnaud Roth, Julien Domont, Daniel Dietrich, Roman Inauen, Piotr Rutkowski, Maud Toulmonde, R. Burkhard, Heike Schwarb, Serge Leyvraz, Roger von Moos
Publikováno v:
Cancer. 124:1449-1454
BACKGROUND Tyrosine kinase inhibitors (TKIs) have improved the outcome of patients with gastrointestinal stromal tumors (GISTs), but most patients eventually develop resistance and progress. Dasatinib is a potent inhibitor of BCR-ABL, KIT, and SRC fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::875a0050fee3a7455d4a4f8d31899ebb
https://doi.org/10.1002/cncr.31234
https://doi.org/10.1002/cncr.31234
Autor:
Michael, Montemurro, Angela, Cioffi, Julien, Dômont, Piotr, Rutkowski, Arnaud D, Roth, Roger, von Moos, Roman, Inauen, Maud, Toulmonde, Roger O, Burkhard, Claudio, Knuesli, Sebastian, Bauer, Philippe, Cassier, Heike, Schwarb, Axel, Le Cesne, Dieter, Koeberle, Daniela, Bärtschi, Daniel, Dietrich, Christine, Biaggi, John, Prior, Serge, Leyvraz
Publikováno v:
Cancer. 124(7)
Tyrosine kinase inhibitors (TKIs) have improved the outcome of patients with gastrointestinal stromal tumors (GISTs), but most patients eventually develop resistance and progress. Dasatinib is a potent inhibitor of BCR-ABL, KIT, and SRC family kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5885c18e24ca4f853881292c488251d
https://pubmed.ncbi.nlm.nih.gov/29315500
https://pubmed.ncbi.nlm.nih.gov/29315500